share_log

Press Release: HealthWarehouse.com Reports -2-

Press Release: HealthWarehouse.com Reports -2-

新闻稿:HealthWarehouse.com报告-2-
Dow Jones Newswires ·  2021/11/15 22:10

Adjusted EBITDA should not be considered as an alternative to net income, net loss or to net cash provided by or used in operating activities as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company's performance.

调整后的EBITDA不应被视为净收益、净亏损或由经营活动提供或用于经营活动的净现金的替代,以此作为衡量经营业绩或流动性的指标。它可能无法与其他公司使用的类似名称的衡量标准相比较,而且它排除了一些人可能认为对评估公司业绩很重要的财务信息。

Reconciliation of Net Income (Loss) (GAAP) to Adjusted EBITDA 
(Non-GAAP)
Three Months Ended Nine Months Ended
September 30, September 30,
--------------------- ------------------------
(Unaudited) 2021 2020 2021 2020
---------- --------- ---------- ------------
Net loss $(181,031) $(15,692) $(493,866) $(177,420)
Interest
expense 43,678 45,530 130,554 160,001
Depreciation
and
amortization 34,210 33,319 100,770 100,282
-------- ------- -------- --------
EBITDA (non-GAAP) (103,143) 63,157 (262,542) 82,863
Adjustments to
EBITDA:
Stock-based
compensation 192,940 125,475 564,090 367,817
-------- ------- -------- --------
Adjusted EBITDA $ 89,797 $188,632 $ 301,548 $ 450,680
======== ======= ======== ========
净收益(亏损)(GAAP)与调整后EBITDA的对账(非GAAP)截至三个月截至九个月九月三十号,九月三十号,                     ---------------------  ------------------------ (未经审计)2021 2020 2021 2020                     ----------  ---------  ----------  ------------ 净亏损$(181,031)$(15,692)$(493,866)$(177,420)利息费用43,678 45,530 130,554 160,001折旧和摊销34,210 33,319 100,770 100,282                      --------    -------    --------    -------- EBITDA(非GAAP)(103,143)63,157(262,542)82,863调整到EBITDA:基于股票的薪酬192,940 125,475 564,090 367,817                      --------    -------    --------    -------- 调整后的EBITDA$89,797$188,632$301,548$450,680                      ========    =======    ========    ======== 

About HealthWarehouse.com

关于HealthWarehouse.com

HealthWarehouse.com, Inc. (OTCQB: HEWA), a technology company with a focus on healthcare e-commerce, sells and delivers prescription medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). HealthWarehouse.com provides a platform focused on increasing access and reducing costs of healthcare products for consumers nationwide. Based in Florence, Kentucky, the Company operates America's Leading Online Pharmacy and a pioneer in affordable healthcare. As one of the first National Association of Boards of Pharmacy ("NABP") Approved Digital Pharmacies, HealthWarehouse.com services the mission of providing affordable healthcare and incredible patient services to help Americans. Learn more at www.HealthWarehouse.com .

HealthWarehouse.com,Inc.(场外交易市场代码:HEWA)是一家专注于保健电子商务的技术公司,通过全国药房理事会协会(NABP)作为经批准的数字药房向所有50个州销售和提供处方药。HealthWarehouse.com提供了一个平台,专注于增加全国消费者获得保健产品的机会并降低其成本。该公司总部设在肯塔基州佛罗伦萨,经营着美国领先的在线药房,是负担得起的医疗保健领域的先驱。作为首批获得全美药房协会(NABP)批准的数字药房之一,HealthWarehouse.com的使命是提供负担得起的医疗保健和令人难以置信的患者服务,帮助美国人。欲了解更多信息,请访问www.HealthWarehouse.com。

Forward-Looking Statements

前瞻性陈述

This announcement and the information incorporated by reference herein contain "forward-looking statements" as defined in federal securities laws, including but not limited to Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, which statements are based on our current expectations, estimates, forecasts and projections. Statements that are not historical facts, including statements about the beliefs, expectations and future plans and strategies of the Company, are forward-looking statements. Actual results may differ materially from those expressed in forward looking statements or in management's expectations. Important factors which could cause or contribute to actual results being materially and adversely different from those described or implied by forward looking statements include, among others, risks related to competition, management of growth, access to sufficient capital to fund our business and our growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, cyber-attacks, access to sufficient inventory, government regulation and taxation, payments, and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's audited Annual Reports and Quarterly Reports available at otcmarkets.com and prior filings with the Securities and Exchange Commission.

本公告和本文引用的信息包含联邦证券法中定义的“前瞻性陈述”,包括但不限于1933年“证券法”第27A节、1934年“证券交易法”第21E节和1995年“私人证券诉讼改革法”,这些陈述是基于我们目前的预期、估计、预测和预测作出的。“前瞻性陈述”包括但不限于1933年“证券法”第27A节、1934年“证券交易法”第21E节和1995年“私人证券诉讼改革法”。非历史事实的陈述,包括有关公司的信念、预期以及未来计划和战略的陈述,均为前瞻性陈述。实际结果可能与前瞻性陈述或管理层的预期大不相同。可能导致或导致实际结果与前瞻性表述中描述或暗示的结果大不相同和不利的重要因素包括但不限于与竞争、增长管理、获得足够资本为我们的业务和增长提供资金、新产品、服务和技术、经营结果的潜在波动、国际扩张、法律诉讼和索赔的结果、履行中心优化、季节性、商业协议、收购和战略交易、汇率、系统中断、网络攻击、获得足够的库存、政府监管和税收、支付和欺诈等相关风险。有关可能影响HealthWarehouse.com财务结果的因素的更多信息,请参见HealthWarehouse.com的审计年度报告和季度报告,这些报告可在otcmarket网站上查阅,也可在之前提交给证券交易委员会的文件中查阅。

View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005223/en/

在business wire.com上查看源代码版本:https://www.businesswire.com/news/home/20211115005223/en/

    CONTACT: 
联系方式:

Joseph Peters, President and CEO, (800) 748-7001

约瑟夫·彼得斯,总裁兼首席执行官,电话:(800)748-7001

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发